Research products
Retatrutide
EUR 49.99
Product Overview
Research use only
Retatrutide (LY3437943) is an investigational single-molecule agonist of the GIP, GLP-1 and glucagon receptors. It has been developed by Eli Lilly as a triple-hormone-receptor agonist and has progressed through large clinical development programmes in obesity and metabolic disease.
Product information
Research classification: long-acting, multi-receptor incretin/glucagon-pathway peptide. Its scientific interest is the combined activation of three receptor systems with overlapping but distinct effects on energy intake, glucose regulation and energy expenditure. A research product should be identified analytically as retatrutide rather than only the informal label “Reta.”